tetradecanoylphorbol acetate has been researched along with 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar-Quesada, R; García Del Moral, R; Martin-Oliva, D; Martínez-Romero, R; Muñoz-Gámez, JA; O'valle, F; Oliver, FJ; Piris, MA; Ruiz de Almodóvar, JM; Villuendas, R | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone
| Article | Year |
|---|---|
Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
Topics: Animals; Carcinogens; Cell Transformation, Neoplastic; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Hypoxia-Inducible Factor 1, alpha Subunit; Isoquinolines; Mice; Mice, Inbred C57BL; NF-kappa B; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 2006 |